Skip to content

13F-HR/A filed by AMERIPRISE FINANCIAL INC

AMERIPRISE FINANCIAL INC filed this 13F-HR/A for the quarter ended 2026-03-31, filed 2026-07-17, with 2 holding rows worth $2,472,465.

Accession
0001193125-26-307058
Filed
2026-07-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A combination report, amendment of type new holdings, 2 entries on the cover page, a total value of $2,472,465 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,472,465 with VALUE read as dollars as filed, 13F file number 028-00139. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.

Other managers

  • reports for this filerColumbia Management Investment Advisers, LLC 028-10477
  • included managerColumbia Management Investment Advisers, LLC 028-10477

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZURA BIO LTDG9TY5A101COMMON STOCK282,207$1,679,132dollars as filed
Milestone Pharmaceuticals Inc59935V107COM666,666$793,333dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001193125-26-225866 superseded2026-05-15acceptance time not in the bulk data set
13F-HR/A 0001193125-26-307051 base2026-07-17acceptance time not in the bulk data set
13F-HR/A 0001193125-26-307058this filing2026-07-17acceptance time not in the bulk data set